Fibroblast growth factor antagonists

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Hormones – e.g. – prolactin – thymosin – growth factors – etc.

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530324, 530325, 530326, 530327, 530328, 930 21, 930120, 930DIG530, C07K 1300, C07K 708, C07K 710, C07K 706

Patent

active

052527182

ABSTRACT:
Antagonists to basic fibroblast growth factor, a 146 amino acid residue polypeptide, are produced. These antagonists are generally between 10 and 45 residues in length and are characterized by their ability to interact with the FGF receptor and/or inhibit and therefore modulate endothelial and other cell growth in vitro and also in vivo. These antagonists includes the sequence of bovine basic FGF(106-115), namely Tyr-Arg-Ser-Arg-Lys-Tyr-Ser-Ser-Trp-Tyr or a sequence having equivalent residues substituted therein. These peptides are also antagonistic to acidic FGF and other members of the family of FGF peptides. They are effective to combat FGF-promoted mitosis in melanomas and the like.

REFERENCES:
patent: 4218474 (1990-08-01), Barnish
patent: 5132408 (1992-07-01), Baird
Rittle et al., Experientia, 37 (2), 246-248, 1976.
R. Kaner et al., Science, 248, 1410-1413, 1990.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Fibroblast growth factor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fibroblast growth factor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibroblast growth factor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1905809

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.